Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.78 |
| Open | 6.65 |
| Bid | 6.66 x 500 |
| Ask | 6.70 x 200 |
| Day's range | 6.51 - 6.79 |
| 52-week range | 2.29 - 6.98 |
| Volume | |
| Avg. volume | 1,552,149 |
| Market cap | 2.062B |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.73 |
| Earnings date | 04 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.00 |
Business WireAmneal to Participate at Upcoming Investor Conference
BRIDGEWATER, N.J., May 22, 2024--Amneal to Participate at Upcoming Investor Conference
Business WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
BRIDGEWATER, N.J., May 22, 2024--Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
GuruFocus.comInsider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)
On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a sale of 38,000 shares of the company.
© 2024 Yahoo. All rights reserved.